{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-013845","form_type":"8-K","ticker":"CVSA","cik":"0000730464","company_name":"Covista Inc.","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.935918+00:00","generated_at":"2026-05-30T09:29:05.625937+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Adtalem Q1 FY2025: Revenue up 13.2%, adj. EPS $1.29 (+38.7% YoY); raises FY guidance","bullets":["Revenue $417.4M (+13.2% YoY); net income $46.2M vs $10.6M prior year; adj. EPS $1.29 vs $0.93.","Total enrollment 90,140, up 11.2% YoY; Chamberlain +11.7%, Walden +12.2%, Medical/Vet -0.7%.","FY2025 guidance raised: revenue $1,690M-$1,730M; adj. EPS $5.75-$5.95 (14.5%-18.5% growth).","Repurchased $34M of shares; $178M remaining under $300M buyback program through Jan 2027.","Repriced $253M Term Loan B, reducing interest rate by 75 bps; net leverage 1.0x."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-013845","json":"https://secwatch.observer/filing/0001558370-24-013845.json","markdown":"https://secwatch.observer/filing/0001558370-24-013845.md","text":"https://secwatch.observer/filing/0001558370-24-013845.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/0001558370-24-013845-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/730464/000155837024013845/atge-20241029x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:29:05.625937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}